Displaying 5341 - 5360 of 5993
| Contract Number | Brand Code | Brand Name | Active Ingredient | Trade Name | Package Size | Formulary Category | Pkg Price | Unit Price | Unit Description | Max. Reimbursable Quantity / Month | Package Description | Manufacturer Code | Manufacturer Name | Agent Code | Agent Name | Benefit | Therapeutic Code | Therapeutic Desc | Drug Contract Start Date | Drug Contract End Date | Status Description | Default Route | Max Repeats | Therapeutic Head | Amend Date | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 41 | A6812 | COMBIVIR 150MG|300MG TAB (GSK) LAMIVUDINE|ZIDOVUDINE (BL) | LAMIVUDINE|ZIDOVUDINE | COMBIVIR | 60'S | BL | 149.83 | 2.4972 | TAB | 60 | BOX | GSK | GLAXOSMITHKLINE | COL | COLLINS LTD | 08180820 | NRTI | 2024-04-01 | 2026-03-31 | ORAL | 6 | NRTI | |||||
| 40 | A681AM | EFAVIRENZ | EMTRICITABINE | TENOFOVIR 600MG | 200MG | 300MG TAB (MAT/AHI) | EFAVIRENZ|EMTRICITABINE|TENOFOVIR | EFAVIRENZ|EMTRICITABINE|TENOFOVIR | 30'S | BL | 27.59 | 0.92 | TABLET | 0 | TAB | MAT | MYLAN LABORATORIES | AHI | ARMSTRONG HEALTHCARE INC | 08180892 | ANTIRETROVIRALS MISCELLANEOUS | 2022-04-01 | 2024-03-31 | Oral | 0 | ANTI-INFECTIVE AGENTS | |||||
| 41 | A681AM | EFAVIRENZ|EMTRICITABINE|TENOFOVIR 600MG|200MG|300MG TAB (MAT (BL) | EFAVIRENZ|EMTRICITABINE|TENOFOVIR | EFAVIRENZ|EMTRICITABINE|TENOFOVIR | 30'S | BL | 30.17 | 1.0058 | TAB | 60 | BOX | MAT | MYLAN LABORATORIES | AHI | ARMSTRONG HEALTHCARE INC | 081892 | ANTIVIRALS, MISCELLANEOUS | 2024-04-01 | 2026-03-31 | ORAL | 6 | ANTIVIRALS, MISCELLANEOUS | |||||
| 42 | A681AM | EFAVIRENZ|EMTRICITABINE|TENOFOVIR 600MG|200MG|300MG TAB (MAT | EFAVIRENZ|EMTRICITABINE|TENOFOVIR | EFAVIRENZ|EMTRICITABINE|TENOFOVIR | 30'S | BL | 27.59 | 0.92 | TAB | 60 | BLIS | MAT | MYLAN LABORATORIES | AHI | ARMSTRONG HEALTHCARE INC | 081892 | ANTIVIRALS, MISCELLANEOUS | 2026-04-01 | 2028-03-31 | ORAL | 0 | ANTIVIRALS, MISCELLANEOUS | |||||
| 40 | A681BN | KIVEXA 600MG | 300MG TAB (GSK/COL) ABACAVIR | LAMIVUDINE | ABACAVIR|LAMIVUDINE | KIVEXA | 30'S | BL | 162.04 | 5.40 | TABLET | 0 | TAB | GSK | GLAXOSMITHKLINE | COL | COLLINS LTD | 08180892 | ANTIRETROVIRALS MISCELLANEOUS | 2022-04-01 | 2024-03-31 | Oral | 0 | ANTI-INFECTIVE AGENTS | |||||
| 40 | A681EY | VONAVIR 600MG | 200MG | 300MG TAB (EMC/COL) EFAVIRENZ | EMTRICITABINE | TENOFOVI More ... | EFAVIRENZ|EMTRICITABINE|TENOFOVIR | VONAVIR | 30'S | BL | 81.55 | 2.72 | TABLET | 0 | TAB | EMC | EMCURE PHARMACEUTICALS LTD | COL | COLLINS LTD | 08180892 | ANTIRETROVIRALS MISCELLANEOUS | 2022-04-01 | 2024-03-31 | Oral | 0 | ANTI-INFECTIVE AGENTS | |||||
| 41 | A681EY | VONAVIR 600MG|200MG|300MG TAB (EMC) EFAVIRENZ|EMTRICITABINE| (BL) | EFAVIRENZ|EMTRICITABINE|TENOFOVIR | VONAVIR | 30'S | BL | 86.99 | 2.8995 | TAB | 60 | BOX | EMC | EMCURE PHARMACEUTICALS LTD | COL | COLLINS LTD | 08180892 | ANTIRETROVIRALS MISCELLANEOUS | 2024-04-01 | 2026-03-31 | ORAL | 6 | ANTIRETROVIRALS MISCELLANEOUS | |||||
| 42 | A681EY | VONAVIR 600MG|200MG|300MG TAB (EMC) EFAVIRENZ|EMTRICITABINE| | EFAVIRENZ|EMTRICITABINE|TENOFOVIR | VONAVIR | 30'S | BL | 86.99 | 2.90 | TAB | 60 | BLIS | EMC | EMCURE PHARMACEUTICALS LTD | COL | AVENTA BARBADOS | 08180892 | ANTIRETROVIRALS MISCELLANEOUS | 2026-04-01 | 2028-03-31 | ORAL | 0 | ANTIRETROVIRALS MISCELLANEOUS | |||||
| 40 | A681FC | KIVALA 600MG | 300MG TAB (REM/SBI) ABACAVIR | LAMIVUDINE | ABACAVIR|LAMIVUDINE | KIVALA | 30'S | BL | 82.72 | 2.76 | TABLET | 0 | TAB | REM | REMEDICA LTD | SBI | MASSY DISTRIBUTION (BDOS) LTD | 08180892 | ANTIRETROVIRALS MISCELLANEOUS | 2022-04-01 | 2024-03-31 | Oral | 0 | ANTI-INFECTIVE AGENTS | |||||
| 42 | A681FC | KIVALA 600MG|300MG TAB (REM) ABACAVIR|LAMIVUDINE | ABACAVIR|LAMIVUDINE | KIVALA | 30'S | BL | 57.49 | 1.92 | TAB | 30 | BLIS | REM | REMEDICA LTD | SBI | MASSY DISTRIBUTION (BDOS) LTD | 08180892 | ANTIRETROVIRALS MISCELLANEOUS | 2026-04-01 | 2028-03-31 | ORAL | 0 | ANTIRETROVIRALS MISCELLANEOUS | |||||
| 41 | A681FS | EXATRON 200MG|245MG TAB (REM) EMTRICITAB (BL) | EMTRICITABINE|TENOFOVIR | EXATRON | 30'S | BL | 76.11 | 2.5371 | TAB | 0 | BOTT | REM | REMEDICA LTD | SBI | MASSY DISTRIBUTION (BDOS) LTD | 08180892 | ANTIRETROVIRALS MISCELLANEOUS | 2024-04-01 | 2026-03-31 | ORAL | 0 | ANTIRETROVIRALS MISCELLANEOUS | |||||
| 40 | A681FT | TAVIN-EM 200MG | 300MG TAB (EMC/COL) EMTRICITABINE | TENOFOVIR | EMTRICITABINE|TENOFOVIR | TAVIN-EM | 30'S | BL | 21.20 | 0.71 | TABLET | 0 | TAB | EMC | EMCURE PHARMACEUTICALS LTD | COL | COLLINS LTD | 08180892 | ANTIRETROVIRALS MISCELLANEOUS | 2022-04-01 | 2024-03-31 | Oral | 0 | ANTI-INFECTIVE AGENTS | |||||
| 41 | A681FT | TAVIN-EM 200MG|300MG TAB (EMC) EMTRICITABINE|TENOFOVIR (BL) | EMTRICITABINE|TENOFOVIR | TAVIN-EM | 30'S | BL | 28.13 | 0.9378 | TAB | 60 | BOX | EMC | EMCURE PHARMACEUTICALS LTD | COL | COLLINS LTD | 08180892 | ANTIRETROVIRALS MISCELLANEOUS | 2024-04-01 | 2026-03-31 | ORAL | 6 | ANTIRETROVIRALS MISCELLANEOUS | |||||
| 40 | A681GL | TRUVADA 200MG | 300MG TAB (GIL/COL) EMTRICITABINE | TENOFOVIR | EMTRICITABINE|TENOFOVIR | TRUVADA | 30'S | BL | 129.53 | 4.32 | TABLET | 0 | TAB | GIL | GILEAD | COL | COLLINS LTD | 08180892 | ANTIRETROVIRALS MISCELLANEOUS | 2022-04-01 | 2024-03-31 | Oral | 0 | ANTI-INFECTIVE AGENTS | |||||
| 41 | A681GL | TRUVADA 200MG|300MG TAB (GIL) EMTRICITABINE|TENOFOVIR (BL) | EMTRICITABINE|TENOFOVIR | TRUVADA | 30'S | BL | 129.53 | 4.3176 | TAB | 60 | BOX | GIL | GILEAD | COL | COLLINS LTD | 081892 | ANTIVIRALS, MISCELLANEOUS | 2024-04-01 | 2026-03-31 | ORAL | 6 | ANTIVIRALS, MISCELLANEOUS | |||||
| 40 | A681GP | ATAZOR-R 300MG | 100MG TAB (EMC/COL) ATAZANAVIR | RITONAVIR | ATAZANAVIR|RITONAVIR | ATAZOR-R | 30'S | BL | 75.03 | 2.50 | TABLET | 0 | TAB | EMC | EMCURE PHARMACEUTICALS LTD | COL | COLLINS LTD | 08180892 | ANTIRETROVIRALS MISCELLANEOUS | 2022-04-01 | 2024-03-31 | Oral | 0 | ANTI-INFECTIVE AGENTS | |||||
| 41 | A681GP | ATAZOR-R 300MG|100MG TAB (EMC) ATAZANAVIR|RITONAVIR (BL) | ATAZANAVIR|RITONAVIR | ATAZOR-R | 30'S | BL | 67.96 | 2.2653 | TAB | 60 | BOX | EMC | EMCURE PHARMACEUTICALS LTD | COL | COLLINS LTD | 081892 | ANTIVIRALS, MISCELLANEOUS | 2024-04-01 | 2026-03-31 | ORAL | 6 | ANTIVIRALS, MISCELLANEOUS | |||||
| 42 | A681GP | ATAZOR-R 300MG|100MG TAB (EMC) ATAZANAVIR|RITONAVIR | ATAZANAVIR|RITONAVIR | ATAZOR-R | 30'S | BL | 73.39 | 2.45 | TAB | 60 | BLIS | EMC | EMCURE PHARMACEUTICALS LTD | COL | AVENTA BARBADOS | 081892 | ANTIVIRALS, MISCELLANEOUS | 2026-04-01 | 2028-03-31 | ORAL | 0 | ANTIVIRALS, MISCELLANEOUS | |||||
| 42 | A681GQ | ABACAVIR|LAMIVUDINE 600MG|300MG TAB (CIP) | ABACAVIR|LAMIVUDINE | ABACAVIR|LAMIVUDINE | 30'S | BL | 183.46 | 6.12 | TAB | 30 | BLIS | CIP | CIPLA LTD | AHI | ARMSTRONG HEALTHCARE INC | 081892 | ANTIVIRALS, MISCELLANEOUS | 2026-04-01 | 2028-03-31 | ORAL | 0 | ANTIVIRALS, MISCELLANEOUS | |||||
| 40 | A681GW | BIKTARVY 50MG | 200MG | 25MG TAB (GIL/COL) BICTEGRAVIR | EMTRICITABINE | TENOFOV More ... | BICTEGRAVIR|EMTRICITABINE|TENOFOVIR | BIKTARVY | 30'S | BL | 321.99 | 10.73 | TABLET | 0 | TAB | GIL | GILEAD | COL | COLLINS LTD | 08180892 | ANTIRETROVIRALS MISCELLANEOUS | 2022-04-01 | 2024-03-31 | Oral | 0 | ANTI-INFECTIVE AGENTS | |||||